Goelzer Investment Management Inc. decreased its stake in Hill-Rom Holdings Inc (NYSE:HRC) by 6.2% during the second quarter, Holdings Channel reports. The institutional investor owned 33,407 shares of the medical technology company’s stock after selling 2,220 shares during the period. Goelzer Investment Management Inc.’s holdings in Hill-Rom Holdings were worth $2,660,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HRC. Independent Portfolio Consultants Inc. raised its position in Hill-Rom Holdings by 171.5% in the second quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock valued at $107,000 after buying an additional 849 shares in the last quarter. Meadow Creek Investment Management LLC raised its position in Hill-Rom Holdings by 3.9% in the first quarter. Meadow Creek Investment Management LLC now owns 1,696 shares of the medical technology company’s stock valued at $120,000 after buying an additional 64 shares in the last quarter. Neuburgh Advisers LLC raised its position in Hill-Rom Holdings by 3.9% in the first quarter. Neuburgh Advisers LLC now owns 2,332 shares of the medical technology company’s stock valued at $165,000 after buying an additional 88 shares in the last quarter. Tyers Asset Management LLC raised its position in Hill-Rom Holdings by 3.9% in the first quarter. Tyers Asset Management LLC now owns 2,968 shares of the medical technology company’s stock valued at $210,000 after buying an additional 112 shares in the last quarter. Finally, Bancorpsouth Inc. purchased a new position in Hill-Rom Holdings during the first quarter valued at $210,000. Institutional investors own 84.00% of the company’s stock.

Hill-Rom Holdings Inc (NYSE:HRC) opened at 75.92 on Tuesday. The firm has a market cap of $5.00 billion, a price-to-earnings ratio of 44.24 and a beta of 1.22. Hill-Rom Holdings Inc has a 52 week low of $50.50 and a 52 week high of $84.65. The company has a 50-day moving average of $80.60 and a 200-day moving average of $72.15.

Hill-Rom Holdings (NYSE:HRC) last announced its quarterly earnings data on Friday, July 28th. The medical technology company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. The business had revenue of $689.10 million for the quarter, compared to analyst estimates of $695.50 million. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. The company’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.81 earnings per share. Equities research analysts forecast that Hill-Rom Holdings Inc will post $3.82 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 15th will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.95%. The ex-dividend date is Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio is 41.62%.

TRADEMARK VIOLATION WARNING: This report was published by Daily Political and is owned by of Daily Political. If you are reading this report on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/08/08/hill-rom-holdings-inc-hrc-stake-decreased-by-goelzer-investment-management-inc.html.

HRC has been the topic of several recent analyst reports. Zacks Investment Research upgraded shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $88.00 price objective on the stock in a research note on Monday, June 12th. ValuEngine upgraded shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Stifel Nicolaus upped their price target on shares of Hill-Rom Holdings from $70.00 to $84.00 and gave the company a “buy” rating in a research note on Monday, May 1st. Barclays PLC upped their price target on shares of Hill-Rom Holdings from $75.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, May 1st. Finally, Needham & Company LLC initiated coverage on shares of Hill-Rom Holdings in a research note on Thursday, June 29th. They issued a “buy” rating and a $95.00 price target on the stock. One analyst has rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $88.17.

In other Hill-Rom Holdings news, SVP Paul Sherwood Johnson sold 2,078 shares of Hill-Rom Holdings stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $72.30, for a total value of $150,239.40. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Andreas G. Frank sold 10,660 shares of Hill-Rom Holdings stock in a transaction dated Tuesday, June 6th. The stock was sold at an average price of $78.62, for a total transaction of $838,089.20. Following the completion of the sale, the senior vice president now directly owns 28,988 shares in the company, valued at approximately $2,279,036.56. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.